{"id":8234,"date":"2023-09-06T10:20:18","date_gmt":"2023-09-06T14:20:18","guid":{"rendered":"https:\/\/vaccines.phila.gov\/?post_type=lsvr_notice&p=8234"},"modified":"2024-09-11T15:50:59","modified_gmt":"2024-09-11T19:50:59","slug":"new-vaccine-product-available-through-vfc-prevnar-20","status":"publish","type":"post","link":"https:\/\/vaccines.phila.gov\/index.php\/new-vaccine-product-available-through-vfc-prevnar-20\/","title":{"rendered":"New Vaccine Product Available Through VFC: Prevnar 20"},"content":{"rendered":"

[vc_row][vc_column][vc_column_text]<\/p>\n

New Vaccine Product Available Through VFC: Prevnar 20<\/strong><\/p>\n\n

On June 27, 2023, the CDC approved Prevnar 20 (PCV20) for use in pediatric patients. Beginning September 6, 2023, this Prevnar 20 is available to order for your VFC eligible patients. The Prevnar 13 (PCV13) is no longer available to order through the VFC program.<\/p>\n\n

Sites using Prevnar 13 can now order Prevnar 20. Please make sure Prevnar 20 is added to your EHR before ordering.<\/p>\n\n

Please note, Vaxneuvance and Prevnar 20 are interchangeable. To change the formulation that your site orders, please complete the\u00a0Change Request Form<\/a>. Our team will review your request and reply with next steps. We recommend that sites that are part of a system or are affiliated use the same vaccine presentations across sites to ensure continuity of care and help prevent administration errors.<\/p>\n\n\n

\n
Vaccine Change Request Form<\/strong><\/a><\/div>\n\n<\/div>\n\n\n\n

Prevnar 20<\/strong><\/p>\n\n

PCV20 is now available through the Vaccines Children (VFC) program.<\/p>\n\n\n